Vascular Medicine Experts Unveil New Clinical Data at The VEINS 2026

The conference highlighted significant advancements in venous care, with several studies demonstrating improved patient outcomes through minimally invasive interventions. Manj Gohel, MD, reported that cyanoacrylate closure for C6 disease achieved an 88.1% ulcer healing rate over 24 months, positioning it as a durable alternative for patients often excluded from traditional research. Similarly, interim results from the BERG02 study showed 100% technical success in percutaneous ligation of superficial and perforator veins, with no device-related serious adverse events reported within 30 days.

In the realm of pulmonary and deep vein thrombosis, mechanical thrombectomy technologies continue to gain traction. The STRIKE-PE study, which tracked 1,000 patients treated with computer-assisted vacuum thrombectomy, observed substantial improvements in quality of life and functional capacity at one year. Additionally, the BOLT study confirmed that a single-session, first-line mechanical approach for iliofemoral DVT achieved a 98% thrombus reduction rate. Meanwhile, long-term data from the C-TRACT trial reinforced that iliac vein stenting provides sustained quality-of-life benefits for patients suffering from post-thrombotic syndrome compared to standard care alone.